Physician profile
David E Lent
NPI 1942289541
$130,183.96
in general payments reported to CMS, 2019-2025
23 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $22K · 2021: $23K · 2022: $13K · 2023: $567 · 2024: $592 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $128,564.26 | 2019-2025 | Mako, Accolade, Gamma |
| Horizon Therapeutics Plc | $305.42 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $305.10 | 2024-2025 | Tapestry, Avenir |
| Ermi LLC | $102.40 | 2020-2021 | |
| Fidia Pharma USA INC. | $101.86 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $94.38 | 2019-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $68.83 | 2019 | |
| Bioventus LLC | $67.09 | 2024 | Durolane |
| Pacira Pharmaceuticals Incorporated | $65.28 | 2022-2023 | Iovera |
| Vertex Pharmaceuticals Incorporated | $62.78 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $60.86 | 2023 | Seglentis |
| Smith+Nephew, INC. | $59.42 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Gotham Surgical Solutions & Devices, INC. | $42.90 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $41.97 | 2021 | |
| Endo Pharmaceuticals INC. | $37.52 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $34.73 | 2019-2020 | |
| Orthofix Medical, INC. | $32.82 | 2023 | Spinal-Stim, Spinal-Stim |
| Dynasplint Systems INC. | $32.00 | 2019 | |
| Boston Scientific Corporation | $28.09 | 2025 | General - Pain Management |
| Trice Medical, INC. | $22.20 | 2019 | |
| Curonix LLC | $20.79 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Endo USA, INC. | $20.51 | 2025 | Xiaflex |
| Pacira Therapeutics, INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.